Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$26.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| Jun 22 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 20,000 | $100.00 | $2M | -22.6% | Open the original filing on SEC.gov |
| Jun 22 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 80,000 | $132.54 | $10.6M | -7.3% | Open the original filing on SEC.gov |
| Jun 10 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 614 | $86.89 | $53.4K | <0.1% | Open the original filing on SEC.gov |
| Jun 10 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,305 | $86.27 | $198.9K | -0.2% | Open the original filing on SEC.gov |
| Jun 10 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,577 | $85.19 | $134.3K | -0.1% | Open the original filing on SEC.gov |
| Jun 10 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,080 | $84.18 | $90.9K | -0.1% | Open the original filing on SEC.gov |
| Jun 10 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 7,654 | $82.78 | $633.6K | -0.7% | Open the original filing on SEC.gov |
| Jun 10 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 6,770 | $82.21 | $556.6K | -0.6% | Open the original filing on SEC.gov |
| May 27 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 8,026 | — | — | — | Open the original filing on SEC.gov |
| May 13 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,341 | $82.58 | $110.7K | -0.1% | Open the original filing on SEC.gov |
| May 13 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 18,659 | $82.05 | $1.5M | -1.6% | Open the original filing on SEC.gov |
| May 8 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 19,269 | $75.35 | $1.5M | -17.9% | Open the original filing on SEC.gov |
| May 8 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 24,814 | $74.76 | $1.9M | -18.7% | Open the original filing on SEC.gov |
| May 8 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 33,513 | $73.72 | $2.5M | -20.2% | Open the original filing on SEC.gov |
| May 8 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 2,404 | $72.57 | $174.5K | -1.4% | Open the original filing on SEC.gov |
| Apr 16 | APGE | Apogee Therapeutics, Inc. | MEXER◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 16 | APGE | Apogee Therapeutics, Inc. | MEXER | 3,000 | $22.86 | $68.6K | +0.3% | Open the original filing on SEC.gov |
| Apr 8 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 200 | $85.00 | $17K | <0.1% | Open the original filing on SEC.gov |
| Apr 8 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,000 | $83.26 | $166.5K | -0.2% | Open the original filing on SEC.gov |
| Apr 8 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 17,800 | $82.48 | $1.5M | -1.5% | Open the original filing on SEC.gov |